Darzalex (daratumumab) - J&J
Rituxan (rituximab) - Roche
Approach to red cell transfusions and stem cell transplant in an alloimmunized sickle cell patient with hyperhemolysis history. (PubMed, Transfusion) - Sep 26, 2026 - "Safe transfusions in SCD patients with hyperhemolysis undergoing HSCT require timely collaboration between laboratory and clinical services, careful selection of matched RBC units for transfusion, extensive serologic testing, and suppression of humoral immune response." 
Journal • Bone Marrow Transplantation • Genetic Disorders • Hematological Disorders • Sickle Cell Disease • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42786794
 
Akash Gupta; Georgina Martin; Sarah Tehseen; Victor Lewis
 
Sep 26, 2026
 
Prev Next